suplatast tosilate has been researched along with Chronic Lung Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujitaka, K; Fukuhara, K; Hamada, H; Hattori, N; Horimasu, Y; Iwamoto, H; Izumi, Y; Masuda, T; Miyamoto, S; Nakashima, T; Sakamoto, S; Shioya, S; Yamaguchi, K | 1 |
Abe, M; Fujitaka, K; Fukuhara, K; Hamada, H; Hattori, N; Iwamoto, H; Kohno, N; Masuda, T; Nakashima, T | 1 |
2 other study(ies) available for suplatast tosilate and Chronic Lung Injury
Article | Year |
---|---|
Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress.
Topics: Animals; Arylsulfonates; Lung Injury; Mice; Mice, Inbred C57BL; Oxidative Stress; Radiation Injuries, Experimental; Radiation-Protective Agents; Sulfonium Compounds | 2019 |
Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arylsulfonates; Asthma; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Deoxyguanosine; DNA Damage; Humans; Hydroxyl Radical; Interleukin-6; Lipid Peroxidation; Lung; Lung Injury; Mice; Oxidative Stress; Reactive Oxygen Species; Sulfonium Compounds; Th2 Cells | 2017 |